SEC Form 4 · accession 0000919574-16-013777
Celator Pharmaceuticals Inc · CPXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jun 21, 2016
Accepted (ET)
Jun 22, 2016 · 3:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001327467
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 21, 2016 | G | 88,571 | — | D | 2,157,898 | I | By CDK ASSOCIATES, LLC |
| Common StockF1,F2 | Jun 21, 2016 | G | 564,222 | — | D | 1,593,676 | I | By CDK ASSOCIATES, LLC |
| Common StockF1,F3 | Jun 21, 2016 | G | 564,222 | — | A | 564,222 | I | See Footnote |
| Common StockF1,F2 | Jun 21, 2016 | G | 1,926 | — | D | 1,591,750 | I | By CDK ASSOCIATES, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction represents a gift/charitable donation effective June 21, 2016. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.
- F2These securities are owned directly by CDK Associates, LLC, which is a reporting person. The securities directly owned by CDK Associates, LLC may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Each of Caxton Corporation and Bruce Kovner disclaims beneficial ownership of these securities except to the extent of its or his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed to be an admission of the beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
- F3These securities are owned directly by an investment entity wholly-owned by Bruce Kovner's family's charitable foundation and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of the investment entity wholly-owned by the foundation, and (ii) Bruce Kovner, the co-chairman of the foundation and the chairman and sole shareholder of Caxton Corporation. Each of Caxton Corporation and Bruce Kovner disclaims beneficial ownership of these securities except to the extent of its or his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed to be an admission of the beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
Remarks
Scott Morenstein, a director of the Issuer, is an employee of Caxton Alternative Management LP, an affiliate of Caxton Corporation.